MAST1 and cancer: Activation of MAST1 promoter was only observed in cancer cells treated with cisplatin, but not with other DNA damaging agents such as mitomycin C or camptothecin (CPT), demonstrating that the MAST1 induction occurs specifically through cisplatin (Fig. 2i; Supplementary Fig. 1d).